000 | 01835 a2200469 4500 | ||
---|---|---|---|
005 | 20250515171040.0 | ||
264 | 0 | _c20090729 | |
008 | 200907s 0 0 eng d | ||
022 | _a1083-4087 | ||
024 | 7 |
_a10.18553/jmcp.2009.15.4.323 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBelperio, Pamela S | |
245 | 0 | 0 |
_aProvider prescribing of 4 antiretroviral agents after implementation of drug use guidelines in the Department of Veterans Affairs. _h[electronic resource] |
260 |
_bJournal of managed care pharmacy : JMCP _cMay 2009 |
||
300 |
_a323-34 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Retroviral Agents _xtherapeutic use |
650 | 0 | 4 | _aAtazanavir Sulfate |
650 | 0 | 4 | _aDarunavir |
650 | 0 | 4 | _aEnfuvirtide |
650 | 0 | 4 |
_aGuideline Adherence _xstatistics & numerical data |
650 | 0 | 4 | _aGuidelines as Topic |
650 | 0 | 4 |
_aHIV Envelope Protein gp41 _xtherapeutic use |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 | _aHealth Plan Implementation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOligopeptides _xtherapeutic use |
650 | 0 | 4 |
_aPeptide Fragments _xtherapeutic use |
650 | 0 | 4 |
_aPractice Patterns, Physicians' _xstatistics & numerical data |
650 | 0 | 4 |
_aPyridines _xtherapeutic use |
650 | 0 | 4 |
_aPyrones _xtherapeutic use |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUnited States Department of Veterans Affairs |
700 | 1 | _aMole, Larry X | |
700 | 1 | _aBoothroyd, Derek B | |
700 | 1 | _aBackus, Lisa I | |
773 | 0 |
_tJournal of managed care pharmacy : JMCP _gvol. 15 _gno. 4 _gp. 323-34 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18553/jmcp.2009.15.4.323 _zAvailable from publisher's website |
999 |
_c18850812 _d18850812 |